UPDATE 1-FDA approves Sanofi/Regeneron cholesterol drug with limits

WASHINGTON, July 24 (Reuters) - The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.